Veeva Systems’ President and Chief Customer Officer Completes Scheduled Sale of 5,000 Shares

Details and Timing of Executive Stock Sale

Thomas D. Schwenger, serving as President and Chief Customer Officer at Veeva Systems, completed the sale of 5,000 Class A common shares on July 16, 2026, at $200 each, generating gross proceeds from the transaction. This sale represents a portion of Schwenger’s equity stake in the cloud software company specializing in the life sciences sector.

The transaction was carried out according to a pre-approved trading arrangement. Schwenger implemented a Rule 10b5-1 trading plan on October 14, 2025, which set predetermined conditions for stock sales. This plan allows insiders to sell shares on a fixed schedule established during periods when they lack material nonpublic information, ensuring compliance with insider trading laws.

Beneficial Ownership After the Transaction

Following the sale, Schwenger’s beneficial ownership of Veeva Systems Class A common stock stands at 20,449 shares. The filing indicates these shares are held directly, not through intermediaries or trusts. This stake reflects his ownership beyond any equity compensation or stock options.

Maintaining this level of ownership positions Schwenger as a significant shareholder in the company he helps lead. His role encompasses customer relations, success operations, and delivering customer value—key factors in Veeva Systems’ competitive positioning within the cloud software market for pharmaceutical, biotechnology, and medical device companies worldwide.

Veeva Systems’ Market Role and Business Model

Veeva Systems provides cloud-based software solutions tailored exclusively for the life sciences industry, serving pharmaceutical, biotechnology, medical device manufacturers, and contract research organizations throughout the product lifecycle. Its cloud platform supports operations management, regulatory compliance, and commercialization efforts.

Schwenger’s executive responsibilities align closely with the company’s customer-centric approach, focusing on strengthening client relationships, enhancing customer success, and expanding service offerings. The life sciences software market is a specialized, regulated sector where customer retention and revenue growth are critical for sustained success.

Compliance Through Rule 10b5-1 Trading Plan

The stock sale was executed under a Rule 10b5-1 trading plan established on October 14, 2025. This regulatory framework enables company insiders to set binding instructions for buying or selling securities during periods when they do not possess material nonpublic information. The plan then operates automatically, removing discretionary timing from the insider.

Rule 10b5-1 plans provide an affirmative defense against insider trading allegations by showing transactions were made in good faith without access to material nonpublic information. Many executives use these plans to systematically manage equity diversification while adhering to securities laws and company policies.

Stock Price Context and Market Impact

The $200 per share sale price offers insight into Veeva Systems’ valuation at the time of the transaction. Public information does not clarify the immediate impact on the stock price. Price fluctuations after insider trades depend on broader market trends, investor sentiment in technology and life sciences sectors, company-specific news, and the trade’s significance relative to overall volume.

While insider sales can attract investor attention as potential indicators of management confidence, Rule 10b5-1 plans operate on preset schedules and should not be interpreted as real-time management sentiment, since they were arranged months prior under different market conditions.

Executive Role and Responsibilities at Veeva Systems

Schwenger’s dual role as President and Chief Customer Officer places him among Veeva Systems’ key operational leaders. This combination highlights the company’s strategic emphasis on customer success, encompassing acquisition, onboarding, retention, revenue expansion, and satisfaction metrics.

In the cloud software industry, especially within regulated verticals like life sciences, customer success is directly linked to revenue stability and growth. Clients engaged in regulated manufacturing and commercialization require continuous support and customization. Schwenger’s position centralizes him in Veeva’s customer value delivery and relationship management strategies, making his equity ownership alignment with shareholders an important governance aspect.

Regulatory Disclosure and Filing Details

The transaction disclosure was filed under Section 16(a) of the Securities Exchange Act of 1934, which mandates officers, directors, and ten-percent beneficial owners to report equity ownership changes. The filing details the transaction date, securities involved, quantities, prices, resulting ownership, and legal authorization.

Schwenger’s designation as a reporting person confirms his insider status at Veeva Systems. The filing on July 20, 2026, followed the July 16 transaction date, complying with regulatory deadlines. These disclosures promote transparency for investors, market participants, and regulators regarding insider equity transactions.

Competitive Landscape in Life Sciences Software

Veeva Systems competes in the specialized life sciences software market, offering cloud solutions for pharmaceutical, biotechnology, and medical device companies. Its platform addresses operational needs including regulatory compliance, quality management, manufacturing data, and commercialization processes. The highly regulated industry demands sophisticated software integrating compliance, security, and operational efficiency.

Ongoing digital transformation in life sciences, driven by regulatory and operational complexity, sustains demand for cloud solutions. Veeva’s market position relies on innovation, strong customer relationships, implementation excellence, and expanding product capabilities. Schwenger’s executive role underscores the importance of post-sale customer engagement and value realization in this competitive environment.

Insider Ownership Trends and Alignment with Shareholders

The disclosure shows Schwenger retains significant direct equity ownership after the sale. By selling only 5,000 shares while holding 20,449, he demonstrates continued confidence in Veeva’s strategic direction and financial outlook. Executive equity ownership aligns management interests with shareholders, as executives share in the company’s performance outcomes.

Structured reductions in insider holdings through trading plans are common for managing compensation and wealth. The modest scale of this sale relative to Schwenger’s total ownership indicates measured diversification rather than a major reduction of exposure. Such transactions provide investors insight into insider views on valuation while maintaining compliance with regulations that prevent opportunistic trading based on nonpublic information.